{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:52:52Z","timestamp":1790117572506,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010211","name":"Education Department of Jilin Province","doi-asserted-by":"publisher","award":["JJKH20250699KJ"],"award-info":[{"award-number":["JJKH20250699KJ"]}],"id":[{"id":"10.13039\/501100010211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002838","name":"Changchun Institute of Applied Chemistry, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002838","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51873023"],"award-info":[{"award-number":["51873023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcis.2025.139093","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T03:56:10Z","timestamp":1758686170000},"page":"139093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Targeting chiral carbon dots to enhance melanoma immunotherapy"],"prefix":"10.1016","volume":"703","author":[{"given":"Ranran","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jcis.2025.139093_bb0005","doi-asserted-by":"crossref","first-page":"24593","DOI":"10.1021\/acsnano.3c10212","article-title":"Advanced generation therapeutics: biomimetic nanodelivery system for tumor immunotherapy","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"30","key":"10.1016\/j.jcis.2025.139093_bb0010","article-title":"From design to clinic: engineered nanobiomaterials for immune normalization therapy of cancer","volume":"33","author":"Saeed","year":"2021","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.jcis.2025.139093_bb0015","first-page":"1640","article-title":"Hyperprogression during immunotherapy","volume":"4","author":"Leake","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.jcis.2025.139093_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mattod.2023.03.006","article-title":"Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment","volume":"65","author":"Erfani","year":"2023","journal-title":"Mater. Today"},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-023-01720-2","article-title":"Immunotherapies in rare cancers","volume":"22","author":"Vivekanandhan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.jcis.2025.139093_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","article-title":"Dissecting the mechanisms of immune checkpoint therapy","volume":"20","author":"Sharma","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"33","key":"10.1016\/j.jcis.2025.139093_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202401749","article-title":"Multifunctional nanovaccine sensitizes breast cancer to immune checkpoint therapy","volume":"34","author":"Peres","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"30","key":"10.1016\/j.jcis.2025.139093_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202312500","article-title":"Self-carrier nanoparticles for delivery of paclitaxel and IDO inhibitor to boost antitumor chemo-immunotherapy","volume":"34","author":"Li","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12951-023-02083-y","article-title":"Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy","volume":"21","author":"Kiaie","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jcis.2025.139093_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216767","article-title":"Liquid biopsy for cancer immunotherapy: biomarkers to predict and monitor response upon immune checkpoint blockade","volume":"539","author":"Son","year":"2025","journal-title":"Coord. Chem. Rev."},{"issue":"16","key":"10.1016\/j.jcis.2025.139093_bb0060","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1200\/JCO.2022.40.16_suppl.12001","article-title":"Correlation of psychological distress with quality of life and efficacy of immune checkpoint inhibitors in patients with newly diagnosed stage IIIB-IV NSCLC","volume":"40","author":"Wu","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"49","key":"10.1016\/j.jcis.2025.139093_bb0065","doi-asserted-by":"crossref","first-page":"33366","DOI":"10.1021\/acsnano.4c08448","article-title":"Anti-PD-L1 antibody fragment linked to tumor-targeting lipid nanoparticle can eliminate cancer and its metastasis via photoimmunotherapy","volume":"18","author":"Park","year":"2024","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.jcis.2025.139093_bb0070","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.jcis.2025.139093_bb0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.trecan.2024.06.003","article-title":"Next-generation cancer vaccines and emerging immunotherapy combinations","volume":"10","author":"Brandenburg","year":"2024","journal-title":"Trends Cancer"},{"issue":"7","key":"10.1016\/j.jcis.2025.139093_bb0080","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/2159-8290.CD-25-0300","article-title":"The future of personalized cancer vaccines","volume":"15","author":"Martini","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jcis.2025.139093_bb0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jconrel.2024.10.057","article-title":"Extracellular vesicles powered cancer immunotherapy: targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model","volume":"376","author":"Mathlouthi","year":"2024","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jcis.2025.139093_bb0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ccell.2023.03.003","article-title":"Adoptive cell transfer immunotherapy for patients with solid epithelial cancers","volume":"41","author":"Rosenberg","year":"2023","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jcis.2025.139093_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/exd.14707","article-title":"Adoptive cell transfer therapy for melanoma","volume":"32","author":"Inozume","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.jcis.2025.139093_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccell.2020.12.022","article-title":"Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective","volume":"39","author":"Ramelyte","year":"2021","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.jcis.2025.139093_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15169","article-title":"Treatment of malignant melanoma with coxsackievirus A21 (V937): An emerging oncolytic virotherapy","volume":"33","author":"Sakunchotpanit","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.jcis.2025.139093_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trecan.2024.11.007","article-title":"Intratumoral immune cell manipulations as a strategy to enhance cancer vaccine efficiency","volume":"11","author":"Adeosun","year":"2025","journal-title":"Trends Cancer"},{"issue":"6","key":"10.1016\/j.jcis.2025.139093_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006628","article-title":"Vaccinating against cancer: getting to prime time","volume":"11","author":"Chang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.jcis.2025.139093_bb0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/0008-5472.CAN-23-2042","article-title":"Targeting tumor heterogeneity with neoantigen-based cancer vaccines","volume":"84","author":"Pounraj","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jcis.2025.139093_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122856","article-title":"Recent progress in cancer vaccines and nanovaccines","volume":"314","author":"Poudel","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcis.2025.139093_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102383","article-title":"The current clinical landscape of personalized cancer vaccines","volume":"106","author":"Fritah","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"51","key":"10.1016\/j.jcis.2025.139093_bb0135","doi-asserted-by":"crossref","first-page":"56666","DOI":"10.1021\/acsami.2c20019","article-title":"Mechanistic insights into the superior DNA delivery efficiency of multicomponent lipid nanoparticles: an in vitro and in vivo study","volume":"14","author":"Quagliarini","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"17","key":"10.1016\/j.jcis.2025.139093_bb0140","doi-asserted-by":"crossref","first-page":"16204","DOI":"10.1021\/acsnano.4c15765","article-title":"Cancer nanovaccines: mechanisms, design principles, and clinical translation","volume":"19","author":"Zaccariotto","year":"2025","journal-title":"ACS Nano"},{"issue":"25","key":"10.1016\/j.jcis.2025.139093_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300299","article-title":"Polyoxazoline-based nanovaccine synergizes with tumor-associated macrophage targeting and anti-PD-1 immunotherapy against solid tumors","volume":"10","author":"Matos","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jcis.2025.139093_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123331","article-title":"Bioengineered metastatic cancer nanovaccine with a TLR7\/8 agonist for needle-free intranasal immunization","volume":"321","author":"Jung","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcis.2025.139093_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122062","article-title":"Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity","volume":"296","author":"Manna","year":"2023","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.jcis.2025.139093_bb0160","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/acsnano.3c13038","article-title":"Antigen-clustered nanovaccine achieves long-term tumor remission by promoting B\/CD 4 T cell crosstalk","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jcis.2025.139093_bb0165","first-page":"347","article-title":"Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against KitK641E-mutant melanoma","volume":"46","author":"Poudel","year":"2025","journal-title":"Biomed. Mater."},{"issue":"8","key":"10.1016\/j.jcis.2025.139093_bb0170","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1039\/D3TB02381H","article-title":"Sivakumar, chiral nanomaterial-based approaches for diagnosis and treatment of protein-aggregated neurodiseases: current status and future opportunities","volume":"12","author":"Pranav","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.jcis.2025.139093_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s44222-022-00014-4","article-title":"Bioinspired chiral inorganic nanomaterials","volume":"1","author":"Cho","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903878","article-title":"Chiral supraparticles for controllable nanomedicine","volume":"32","author":"Yeom","year":"2020","journal-title":"Adv. Mater."},{"issue":"7893","key":"10.1016\/j.jcis.2025.139093_bb0185","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-021-04243-2","article-title":"Enantiomer-dependent immunological response to chiral nanoparticles","volume":"601","author":"Xu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcis.2025.139093_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108029","article-title":"The influence of component structural arrangement on peptide vaccine immunogenicity","volume":"60","author":"Alharbi","year":"2022","journal-title":"Biotechnol. Adv."},{"issue":"9","key":"10.1016\/j.jcis.2025.139093_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202200033","article-title":"Carbon dots for intracellular sensing","volume":"3","author":"Lin","year":"2022","journal-title":"Small Struct."},{"issue":"31","key":"10.1016\/j.jcis.2025.139093_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202001909","article-title":"Photo-stimulated polychromatic room temperature phosphorescence of carbon dots","volume":"16","author":"Jiang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.jcis.2025.139093_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.112365","article-title":"Tunable fluorescent carbon dots from biowaste as fluorescence ink and imaging human normal and cancer cells","volume":"204","author":"Atchudan","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.jcis.2025.139093_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.143384","article-title":"Carbon dots for long-term near-infrared afterglow imaging and photodynamic therapy","volume":"467","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.matt.2021.10.016","article-title":"The light of carbon dots: from mechanism to applications","volume":"5","author":"Wang","year":"2022","journal-title":"Matter"},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.chempr.2023.09.020","article-title":"Lasing of carbon dots: chemical design, mechanisms, and bright future","volume":"10","author":"Zhang","year":"2024","journal-title":"Chem"},{"issue":"45","key":"10.1016\/j.jcis.2025.139093_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202406096","article-title":"Two birds with one stone: Guanidyl carbon dots with enhanced antioxidative and lipolytic functions in metabolic associated fatty liver","volume":"34","author":"Cai","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"43","key":"10.1016\/j.jcis.2025.139093_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202004680","article-title":"Carbon dots based nanoscale covalent organic frameworks for photodynamic therapy","volume":"30","author":"Chen","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"34","key":"10.1016\/j.jcis.2025.139093_bb0235","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1039\/C6TB01622G","article-title":"Co-assembled hybrids of proteins and carbon dots for intracellular protein delivery","volume":"4","author":"Zhang","year":"2016","journal-title":"J. Mater. Chem. B"},{"issue":"31","key":"10.1016\/j.jcis.2025.139093_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202207868","article-title":"Specific chemiluminescence imaging and enhanced photodynamic therapy of bacterial infections by hemin-modified carbon dots","volume":"19","author":"Cheng","year":"2023","journal-title":"Small"},{"issue":"21","key":"10.1016\/j.jcis.2025.139093_bb0245","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/adma.201306192","article-title":"Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine","volume":"26","author":"Zheng","year":"2014","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.jcis.2025.139093_bb0250","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1021\/acsabm.3c00228","article-title":"Multifaceted carbon dots: toward pH-responsive delivery of 5-fluorouracil for in vitro antiproliferative activity","volume":"6","author":"Kaur","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"issue":"8","key":"10.1016\/j.jcis.2025.139093_bb0255","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1021\/acsabm.4c00633","article-title":"Nanodroplets engineered with folate carbon dots for enhanced cancer cell uptake toward theranostic application","volume":"7","author":"Kumawat","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"7","key":"10.1016\/j.jcis.2025.139093_bb0260","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1039\/D2NA00060A","article-title":"Carbon dot-based fluorescent antibody nanoprobes as brain tumour glioblastoma diagnostics","volume":"4","author":"Ghirardello","year":"2022","journal-title":"Nanoscale Adv."},{"issue":"35","key":"10.1016\/j.jcis.2025.139093_bb0265","doi-asserted-by":"crossref","first-page":"39858","DOI":"10.1021\/acsami.2c11596","article-title":"Unprecedented chiral nanovaccines for significantly enhanced cancer immunotherapy","volume":"14","author":"Liu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jcis.2025.139093_bb0270","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcis.2024.06.101","article-title":"Tumor associated antigens combined with carbon dots for inducing durable antitumor immunity","volume":"673","author":"Liu","year":"2024","journal-title":"J. Colloid Interface Sci."},{"issue":"31","key":"10.1016\/j.jcis.2025.139093_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206683","article-title":"Carbon dots and tumor antigen conjugates as nanovaccines for elevated cancer immunotherapy","volume":"19","author":"Liu","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.jcis.2025.139093_bb0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40824-023-00404-8","article-title":"Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics","volume":"27","author":"Jangid","year":"2023","journal-title":"Biomater. Res."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979725024853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979725024853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T15:22:15Z","timestamp":1763306535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979725024853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S0021979725024853"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2025.139093","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting chiral carbon dots to enhance melanoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2025.139093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"139093"}}